Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 1/20 | 0.37 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.37 |
| ▸ | F2 | P00734 | 3/20 | 0.31 |
| ▸ | XIAP | P98170 | 1/20 | 0.31 |
| ▸ | BIRC3 | Q13489 | 1/20 | 0.31 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11983932 | 0.86 | ADRB3 (0.38) | ADRB3ADRA2BADRA2CXIAPBIRC3 | |
| SCHEMBL11975943 | 0.85 | ADRB3 (0.35) | ADRB3ADRA2BADRA2CHDAC4HDAC1 | |
| SCHEMBL8006962 | 0.85 | DPP4 (0.34) | ADRB3ADRA2BADRA2C | |
| SCHEMBL13082475 | 0.84 | F2 (0.36) | F2XIAPBIRC3BIRC2HDAC4 | |
| SCHEMBL8378473 | 0.83 | ADRB3 (0.42) | ADRB3ADRA2BADRA2CF2XIAP | |
| SCHEMBL8237408 | 0.83 | ADRB3 (0.42) | ADRB3ADRA2BADRA2CF2XIAP | |
| SCHEMBL7999967 | 0.83 | ADRB3 (0.42) | ADRB3ADRA2BADRA2CF2XIAP | |
| SCHEMBL1645865 | 0.83 | ADRB3 (0.42) | ADRB3ADRA2BADRA2CF2XIAP | |
| SCHEMBL13059226 | 0.83 | ADRB3 (0.42) | ADRB3ADRA2BADRA2CF2XIAP | |
| SCHEMBL1645862 | 0.83 | ADRB3 (0.42) | ADRB3ADRA2BADRA2CF2XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7829665-B2 | Macrocyclic inhibitors of hepatitis C virus replication | INTERMUNE, INC. (US) | 2010-11-09 | — | — | US | disclosed |